Drosophila Screening Identifies Dual Inhibition of MEK and AURKB as an Effective Therapy for Pancreatic Ductal Adenocarcinoma

被引：4
|
作者：
Sekiya, Sho [1 ,2 ]
Fukuda, Junki [1 ,2 ]
Yamamura, Ryodai [1 ]
Ooshio, Takako [1 ]
Satoh, Yusuke [1 ]
Kosuge, Shinya [1 ,2 ]
Sato, Reo [1 ]
Hatanaka, Kanako C. [3 ]
Hatanaka, Yutaka [3 ,4 ]
Mitsuhashi, Tomoko [5 ]
Nakamura, Toru [2 ]
Matsuno, Yoshihiro [5 ]
Hirano, Satoshi [2 ]
Sonoshita, Masahiro [1 ,6 ]
机构：
[1] Hokkaido Univ, Inst Genet Med, Div Biomed Oncol, Sapporo 0600815, Japan
[2] Hokkaido Univ, Fac Med, Dept Gastroenterol Surg 2, Sapporo, Japan
[3] Hokkaido Univ Hosp, Ctr Dev Adv Diagnost, Sapporo, Japan
[4] Hokkaido Univ Hosp, Res Div Genome Compan Diagnost, Sapporo, Japan
[5] Hokkaido Univ Hosp, Dept Surg Pathol, Sapporo, Japan
[6] Hokkaido Univ, Global Stn Biosurfaces & Drug Discovery, Sapporo 0600812, Japan
来源：
CANCER RESEARCH | 2023年 / 83卷 / 16期
基金：
日本学术振兴会; 日本科学技术振兴机构;
关键词：
PHASE-1; DOSE-ESCALATION; AURORA-B; CANCER; KINASE; TRAMETINIB; COOPERATE; GEMCITABINE; PROGRESSION; EXPRESSION; KRAS(G12D);
D O I：
10.1158/0008-5472.CAN-22-3762
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Significant progress has been made in understanding the pathogenesis of pancreatic ductal adenocarcinoma (PDAC) by generating and using murine models. To accelerate drug discovery by identifying novel therapeutic targets on a systemic level, here we generated a Drosophila model mimicking the alterations), which is associated with the worst prognosis in patients. The '4-hit' flies displayed epithelial transformation and decreased survival. Comprehensive genetic screening of their entire kinome revealed kinases including MEK and AURKB as therapeutic targets. Consistently, a combination of the MEK
引用
收藏
页码：2704 / 2715
页数：12
相关论文
共 50 条
  • [31] Pharmacological inhibition of Bruton's Tyrosine Kinase (BTK) as a therapy for insulinoma and pancreatic ductal adenocarcinoma
    Masso-Valles, Daniel
    Serrano, Erika
    Whitfield, Jonathan R.
    Buggy, Joseph J.
    Sodir, Nicole M.
    Affara, Nesrine I.
    Swigart, Lamorna Brown
    Evan, Gerard I.
    Soucek, Laura
    CANCER RESEARCH, 2013, 73 (08)
  • [32] Targeting the tumor microenvironment for pancreatic ductal adenocarcinoma therapy
    Zhang, Yi-Fan
    Jiang, Shu-Heng
    Hu, Li-Peng
    Huang, Pei-Qi
    Wang, Xu
    Li, Jun
    Zhang, Xue-Li
    Nie, Hui-Zhen
    Zhang, Zhi-Gang
    CHINESE CLINICAL ONCOLOGY, 2019, 8 (02)
  • [33] Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy
    Collisson, Eric A.
    Sadanandam, Anguraj
    Olson, Peter
    Gibb, William J.
    Truitt, Morgan
    Gu, Shenda
    Cooc, Janine
    Weinkle, Jennifer
    Kim, Grace E.
    Jakkula, Lakshmi
    Feiler, Heidi S.
    Ko, Andrew H.
    Olshen, Adam B.
    Danenberg, Kathleen L.
    Tempero, Margaret A.
    Spellman, Paul T.
    Hanahan, Douglas
    Gray, Joe W.
    NATURE MEDICINE, 2011, 17 (04) : 500 - U140
  • [34] Trends in the utilization of neoadjuvant therapy for pancreatic ductal adenocarcinoma
    Brown, Zachary J.
    Cloyd, Jordan M.
    JOURNAL OF SURGICAL ONCOLOGY, 2021, 123 (06) : 1432 - 1440
  • [35] Evolution of Systemic Therapy in Metastatic Pancreatic Ductal Adenocarcinoma
    Kamgar, Mandana
    Chakrabarti, Sakti
    Shreenivas, Aditya
    George, Ben
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2021, 30 (04) : 673 - 691
  • [36] Advances in Drug Therapy for Metastatic Pancreatic Ductal Adenocarcinoma
    Gao, Jianjun
    Wang, Jiangang
    Guan, Canghai
    Shi, Wujiang
    Dong, Qingfu
    Sheng, Jialin
    Zou, Xinlei
    Xu, Zhaoqiang
    Ge, Yifei
    Huang, Ziyue
    Li, Jiehan
    Bao, Haolin
    Xu, Yi
    Cui, Yunfu
    Xu, Xiaoxue
    Zhong, Xiangyu
    JOURNAL OF CANCER, 2024, 15 (08): : 2214 - 2228
  • [37] Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma
    Yunzhen Qian
    Yitao Gong
    Zhiyao Fan
    Guopei Luo
    Qiuyi Huang
    Shengming Deng
    He Cheng
    Kaizhou Jin
    Quanxing Ni
    Xianjun Yu
    Chen Liu
    Journal of Hematology & Oncology, 13
  • [38] Pancreatic ductal adenocarcinoma: Risk factors, screening, and early detection
    Andrew E Becker
    Yasmin G Hernandez
    Harold Frucht
    Aimee L Lucas
    World Journal of Gastroenterology, 2014, (32) : 11182 - 11198
  • [39] Screening for Pancreatic Ductal Adenocarcinoma: Are We Asking the Impossible?-Response
    Caldwell, Katharine E.
    Hammill, Chet W.
    CANCER PREVENTION RESEARCH, 2021, 14 (10) : 975 - 975
  • [40] Improving the efficacy of dual ERK-MAPK and autophagy inhibition as a therapeutic strategy for pancreatic ductal adenocarcinoma
    DeLiberty, Jonathan M.
    Stalnecker, Clint A.
    Drizyte-Miller, Kristina
    Schechter, Elyse G.
    Pieper, Noah L.
    Yang, Runying
    Der, Channing J.
    Cox, Adrienne D.
    Bryant, Kirsten L.
    CANCER RESEARCH, 2023, 83 (07)
12345